Literature DB >> 2381533

A quantitative evaluation of pontine volume by computed tomography in patients with cerebellar degeneration.

K Chida1, M Tamura, I Kamikura, T Takasu, N Goto.   

Abstract

We used CT to make a quantitative evaluation of the pontine volumes of 55 patients with adult-onset cerebellar degeneration and compared the results with their clinical records. Patients with pontine atrophy showed significantly more autonomic dysfunction and extrapyramidal signs; their other clinical features did not differ from patients without pontine atrophy. After dividing the patients into 2 groups, those with and without autonomic dysfunction or extrapyramidal signs, we found that those with these manifestations also had pontine atrophy, a later onset and shorter duration of the disease, and impairment of higher brain functions. The group without these manifestations had relatively normal pontine volume, a greater familial tendency for cerebellar degeneration, and longer duration of the disease. Our results suggest that quantitative volume evaluation of the pons by CT is important for the clinical categorization of cerebellar degeneration.

Entities:  

Mesh:

Year:  1990        PMID: 2381533     DOI: 10.1212/wnl.40.8.1241

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

Review 1.  Morphometric evaluations of the human nervous system.

Authors:  Noboru Goto; Jun Goto
Journal:  Hum Cell       Date:  2006-05       Impact factor: 4.174

Review 2.  Magnetic resonance imaging in degenerative ataxic disorders.

Authors:  I E Ormerod; A E Harding; D H Miller; G Johnson; D MacManus; E P du Boulay; B E Kendall; I F Moseley; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

3.  Reduced cerebellar blood flow and oxygen metabolism in spinocerebellar degeneration: a combined PET and MRI study.

Authors:  X Sun; M Tanaka; S Kondo; S Hirai; T Ishihara
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.